GEN Exclusives

More »

Best of the Web

More »
Jul 01, 2006 (Vol. 26, No. 13)

Orphanet

URL:www.orpha.net/consor/cgi-bin/home.php?Lng=GB
  • Functions well at several levels
  • None
The problem of rare diseases and orphan drugs is an important one. Our profit-driven health care system has its faults, as we all recognize, but these are magnified even more if you suffer from a rare disease or disorder for which drug developers aren’t willing to create drugs due to a limited market. There is probably more information on Orphanet than there is for some of the rare diseases described therein. Information is available that is targeted at medical professionals, patients, support groups, industrialists, and the general public. Articles are well-written and easy-to-understand. What more could one ask of a site?
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?